Oppenheimer resumed coverage on Abeona Therapeutics with a new price target

6/2/25 8:44:24 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Oppenheimer resumed coverage of Abeona Therapeutics with a rating of Outperform and set a new price target of $19.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ABEO

Date	Price Target	Rating	Analyst
6/2/2025	$19.00	Outperform	Oppenheimer
3/5/2025	$16.00	Outperform	Oppenheimer
7/3/2024	$15.00	Buy	H.C. Wainwright
5/30/2024	$21.00	Buy	Stifel
11/30/2021	$5.00 → $1.00	Outperform → Market Perform	SVB Leerink
11/29/2021	$5.00 → $4.00	Buy	HC Wainwright & Co.
7/19/2021	$8.00 → $5.00	Buy	HC Wainwright & Co.